About Palobiofarma S.L. (molecule owner)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Palobiofarma S.L. (molecule owner)
During the past decade, Palobiofarma S.L. (molecule owner) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Palobiofarma S.L. (molecule owner)"
#1 collaborator was "Palo Biofarma, S.L" with 6 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Palobiofarma S.L. (molecule owner)
According to Clinical.Site data, the most researched conditions in "Palobiofarma S.L. (molecule owner)" are
"Asthma" (3 trials), "Parkinson Disease" (2 trials) and "Huntington's Disease" (1 trials). Many other conditions were trialed in "Palobiofarma S.L. (molecule owner)" in a lesser frequency.
Clinical Trials Intervention Types at Palobiofarma S.L. (molecule owner)
Most popular intervention types in "Palobiofarma S.L. (molecule owner)" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "PBF-509" (2 trials), "PBF-680" (2 trials), "PBF-680 20 mg" (1 trials) and "PBF-680 5 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Palobiofarma S.L. (molecule owner)
The vast majority of trials in "Palobiofarma S.L. (molecule owner)" are
4 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Palobiofarma S.L. (molecule owner)
Currently, there are NaN active trials in "Palobiofarma S.L. (molecule owner)".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Palobiofarma S.L. (molecule owner),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Palobiofarma S.L. (molecule owner), 5 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".